NextPlat closes $1.49M cash purchase of Pensacola-area pharmacy with ~$5.6M FY2025 sales

NextPlat Corp

Total cash consideration of $1,485,439 for the independent pharmacy and its inventory; the Pharmacy generated approximately $5.6 million in sales for the year ended December 31, 2025.
NextPlat said the Pharmacy was profitable, held positive working capital and a debt-free balance sheet, and is expected to add to the PharmcoRx healthcare segment in Q4 2026.
PharmcoRx now operates five pharmacies across northern, central and southern Florida; the deal adds access to the Pensacola market and panhandle region.
CEO David Phipps said the company is 'actively exploring additional opportunities' to acquire established, profitable community pharmacy operators.
Planned rollout of higher-margin contracted services at the site: 340B, long-term care and senior living programs, which the company says are largely unavailable in the region.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.